Narrow search
Showing 1 - 10 of 104
Cover Image
Does pharmaceutical price regulation affect the adoption of generic competition? Evidence from the OECD, 1999-2008
Varol, Nebibe; Costa-Font, Joan; McGuire, Alistair - 2011
efficiency and stimulates pharmaceutical innovation. There is no prior study that has empirically analysed the relative delays in … adoption of generic competition. This paper aims to investigate how price regulations in the OECD affect the adoption of … heterogeneity. Ex-ante profit expectations result in faster adoption; both expected price and market size increase the probability …
Persistent link: https://www.econbiz.de/10010274736
Cover Image
Explaining early adoption on new medicines: Regulation, innovation and scale
Varol, Nebibe; Costa-Font, Joan; McGuire, Alistair - 2011
Understanding how price regulations affect the adoption of new patent-protected pharmaceutical technologies is a … statistically significant and robust price effect in the adoption of new pharmaceutical technologies; low-prices result in reduced … and slower adoption. Concentrated therapeutic subgroups, reflecting market crowding constitutes a significant barrier to …
Persistent link: https://www.econbiz.de/10010274894
Cover Image
Price regulation and relative delays in generic drug adoption
Costa-Font, Joan; McGuire, Alistair; Varol, Nebibe - In: Journal of health economics 38 (2014), pp. 1-9
Persistent link: https://www.econbiz.de/10011282079
Cover Image
The adoption of new prescription drugs is strongly associated with prior category prescribing rate
Stern, Philip; Wright, Malcom - In: International journal of research in marketing : IJRM ; … 33 (2016) 1, pp. 220-224
Persistent link: https://www.econbiz.de/10011490911
Cover Image
Exploring a regional pharmaceutical innovation network as a possible solution to the market failure in the innovation of essential medicines for tropical diseases in sub-Saharan Af...
Manu, Thaddeus - In: African journal of science, technology, innovation & … 6 (2014) 1/2, pp. 111-125
Persistent link: https://www.econbiz.de/10011337301
Cover Image
Markets for pharmaceutical products
Scott Morton, Fiona; Kyle, Margaret K. - 2012
Persistent link: https://www.econbiz.de/10011498384
Cover Image
Evaluating the US pharmaceutical patent policy
Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2021
The debate on whether COVID-19 vaccine patents are slowing down the pace of vaccination and the recovery from the crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in the US pharmaceutical industry. We estimate the effect...
Persistent link: https://www.econbiz.de/10012802183
Cover Image
Optimal patent policy for pharmaceutical industry
Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2020
Persistent link: https://www.econbiz.de/10012439514
Cover Image
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona; Stern, Ariel D.; Stern, Scott - 2017
Persistent link: https://www.econbiz.de/10011708133
Cover Image
Chapter 12. Pharmaceutical Innovation
Scherer, F.M. - 2010
This chapter surveys the costs, risks, and challenges encountered in the progressive discovery and development of new pharmaceuticals. The changing methods by which drugs are discovered, the links between companies and academic science, the changing character of public regulation, and the sharp...
Persistent link: https://www.econbiz.de/10014025164